Global And China Catheter Market, By Product Type (Cardiovascular Catheter, Urology Catheters, Intravenous Catheters, Neurovascular Catheters, Specialty Catheters), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Published In : Jul 2023

Code : CMI4010

Pages :180

Formats :

Excel and PDF

Industry : Medical Devices

Market Challenges And Opportunities

Restraints & Challenges:

High cost of the cardiac catheterization procedure

Global And China Catheter Market– Driver

Increasing prevalence of chronic disorders

Increasing prevalence of chronic disorders is expected to propel growth of the global and China catheters market over the forecast period. For instance, according to the American Heart Association's Heart and Stroke Statistics 2022 update, National prevalence of any chronic diseases was 81.1% (95% Cardiac index 80.9-81.2), representing 179.9 billion Chinese older adults. The prevalence increased with aging and peaked at 80 to 84 years old (87.2, 95% CI 86.7-87.7), this is consistent with studies in China.

Growing geriatric population

Growing geriatric population can also drive the global and china catheter market growth. For instance, according to an article published in World Health Organization in November 2022, reported 1 in 6 people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. By 2050, the world’s population of people aged 60 years and older will double (2.1 billion). Non- cystic fibrosis bronchiectasis is the most common in elderly and frailer patients with estimated cases of 50% in patients over 65 years of age and 19.1% in patients over 75 years old.

Global And China Catheter Market: Restraint

High cost of the cardiac catheterization procedure

High cost of the cardiac catheterization procedure is expected to hinder growth of the market. For instance, Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world, and Medtronic is a leader in medical technology, services, and solutions whose products are used in a broad range of interventional medical specialties, announced Coronary stents, priced at about 13,000 yuan (US$1,961) each, are expected to become available in Chinese hospitals for the treatment of coronary heart disease. The cost of cardiac catheterization with & without coronary angiogram ranges from US$ 3,000 to US$ 5,000.